Preclinical Oncology Models Market Size, Share & Trends Analysis Report By Product (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Others), By Application, By Region, And Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Preclinical Oncology Models Market Snapshot Chapter 4. Global Preclinical Oncology Models Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Analysis of Key Vendors in Cancer Clinical Trial/Pipeline 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape 4.8. Major Investment, Partnerships and Collaborations in Cancer Research Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis 5.1. Product Type & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product: 5.2.1. Patient-Derived Xenograft Models (PDX) 5.2.2. Cell Line Derived Xenograft Models 5.2.3. Syngeneic Models 5.2.4. Genetically engineered mouse models (GEMMs) 5.2.5. Orthotopic Models 5.2.6. Custom Xenograft and Syngeneic Model 5.2.7. Others Chapter 6. Market Segmentation 2: Application Estimates & Trend Analysis 6.1. Application Type & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application: 6.2.1. Neuroblastoma 6.2.2. Prostate Cancer 6.2.3. Pancreatic Cancer 6.2.4. Breast Cancer 6.2.5. Colorectal Cancer 6.2.6. Bladder Cancer 6.2.7. Fibrosarcoma 6.2.8. Kidney Cancer 6.2.9. Liver Cancer 6.2.10. Lung Cancer 6.2.11. Lymphoma 6.2.12. Skin Cancer 6.2.13. Others Chapter 7. Preclinical Oncology Models Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Preclinical Oncology Models Market revenue (US$ Million) estimates and forecasts by product, 2021-2034 7.1.2. North America Preclinical Oncology Models Market revenue (US$ Million) estimates and forecasts by application, 2021-2034 7.1.3. North America Preclinical Oncology Models Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Preclinical Oncology Models Market revenue (US$ Million) by product, 2021-2034 7.2.2. Europe Preclinical Oncology Models Market revenue (US$ Million) by application, 2021-2034 7.2.3. Europe Preclinical Oncology Models Market revenue (US$ Million) by country, 2021-2034 7.2.3.1. Germany 7.2.3.2. France 7.2.3.3. Italy 7.2.3.4. Spain 7.2.3.5. UK 7.2.3.6. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Preclinical Oncology Models Market revenue (US$ Million) by product, 2021-2034 7.3.2. Asia Pacific Preclinical Oncology Models Market revenue (US$ Million) by application, 2021-2034 7.3.3. Asia Pacific Preclinical Oncology Models Market revenue (US$ Million) by country, 2021-2034 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Rest of World 7.4.1. Rest of World Preclinical Oncology Models Market revenue (US$ Million) by product, 2021-2034 7.4.2. Rest of World Preclinical Oncology Models Market revenue (US$ Million) by country, 2021-2034 7.4.2.1. Latin America 7.4.2.2. Middle East & Africa Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Aragen Bioscience 8.2.2. vivoPharm Pty. Ltd. 8.2.3. Bisoduro 8.2.4. Crown Bioscience Inc. 8.2.5. Charles River 8.2.6. Champion Oncology, Inc. 8.2.7. Envigo (Inotive Inc.) 8.2.8. GenOway S.A. 8.2.9. Hera Biolabs, Inc. 8.2.10. MI Bioresearch (Labcorp Inc.) 8.2.11. Pharmatest Services 8.2.12. Taconic Biosciences, Inc 8.2.13. The Jackson Laboratory 8.2.14. Reaction Biology(ProQinase GmbH) 8.2.15. Creative Animodel 8.2.16. Biocytogen 8.2.17. Oncodesign Services 8.2.18. WuXi AppTec 8.2.19. Washington Biotechnology Inc. 8.2.20. XenTech.eu 8.2.21. Other Prominent Player List of Other Prominent Players